Resonant Clinical Solutions Expands Advanced Storage Capabilities Via Acquisition

Resonant Clinical Solutions has expanded its capabilities in advanced-therapy and cryogenic storage through the acquisition of Creapharm Bioservices. The company's latest move strengthens its specialized service offerings within Europe.

This expansion builds upon Resonant's existing global biorepository services and is intended to support complex clinical programs, particularly those involving cell and gene therapies. The acquisition aims to enhance Resonant's role as a partner for the life sciences industry.

Creapharm Bioservices provides expertise and facilities crucial for the preservation of biological materials under stringent conditions. The integration of its operations is expected to address a growing demand for high-quality storage solutions needed for the clinical trials of advanced therapeutic products.

Financial terms of the acquisition were not disclosed. Resonant Clinical Solutions continues to develop its global infrastructure to support clinical programs.